Facebook Is Forcing The Wall On Drug Companies Facebook Pages
Aug 17, 2011 11:46
Facebook is getting pharmaceutical companies to allow pill talk. The AZ Daily Star reports, that pharmaceutical firms were given a rare exception on Facebook, that they don't need to have a wall. To their advantage of course, in case anyone talks about their product in negative light.
The industry "nightmare" is processing of adverse event reports (AERs), said Joe Farris, co-founder of the Digital Health Coalition, a nonprofit group focused on online marketing of health-care products. Users might write on a company's Wall about a specific product causing an unexpected reaction or injury. That information could qualify as an AER, and it must then be filed with the Food and Drug Administration, which uses the reports to monitor product safety.
Now, they're being forced by Facebook to open up, and talking about it of course, is cause for concern. Though, Facebook pages don't just allow helpful discussion, but could act as a check against the less than exhaustive FDA testing. Which is a good thing:
Companies like Pfizer are extremely upfront about their paranoia, and warn you of comment deletion as soon as you land on their FB page. The top two reasons for pulling comments, they say?
Your comment references a Product (ours or someone else's) Your comment references a Side Effect
Tired of locks that don't work and people taking off with your bike? The Yerka Project is an interesting one because it can't be stolen without breaking it. The project is being developed by 3 Chilean students. Watch the video below: Read more
About ten years ago, you wouldn’t see many people walking around with a smartphone or tablet device. Such technology was in its infancy, and most people used their computers at work or home to go on the Internet. Read more
There are many ways to be more productive, but perhaps the best way to do so is to understand why we aren't in the first place. Here are a couple of brain hacks you can use to be a tad bit more productive. Read more